Do you live with hepatitis B and want to help shape the language used to talk about it?

July 24, 2024

INVOLVEMENT OPPORTUNITY – South East London, Hepatitis B 

Do you live with hepatitis B and want to help shape the language used to talk about it? 

A UK Government Agency are developing a language guide that clinicians and other healthcare professionals will refer to when they are interacting with patients. This guide will help to reduce the stigma that HBV patients often face. You are invited to a focus group where you will give your feedback on the work they have undertaken so far, with a particular emphasis on the section around stigma.  

Can I take part? 

Yes, if you are over 18 years old, live in the UK, and are living with a hepatitis B infection. You don’t need to have British citizenship to take part in the research, and you don’t need to have previous experience of attending a focus group. We are looking for a wide range of participants to take part.  

What will I need to do? 

The focus group will take place in South East London on Tuesday 6th August between 2pm and 3pm, and is a five minute walk from London Bridge station. You will be given vouchers in payment for your time and contribution, plus reimbursement of travel costs.  

We will ask you to review the language guide, in particular the section around stigma, and give your feedback on how it can be improved. 

I am interested, what should I do now? 

To book on, or for more information please email: [email protected] 

 

More news

Potential for hundreds more liver transplants after NICE recommends new life-saving liver procedure for NHS use

Potential for hundreds more liver transplants after NICE recommends new life-saving liver procedure for NHS use

The British Liver Trust welcomes the news that hundreds more liver transplants could be carried out after a new procedure that supplies a donor liver with oxygen before removal was approved by NICE for use in the NHS.   In-situ ...
New hope for people living with MASH as two treatments receive MHRA approval

New hope for people living with MASH as two treatments receive MHRA approval

People living with metabolic dysfunction-associated steatohepatitis (MASH) have received encouraging news, with the UK medicines regulator approving two treatments for the condition within the past month. The Medicines and Healthcare ...
New Lancet Commission Highlights the Vital Role of Primary Care in Tackling Liver Disease

New Lancet Commission Highlights the Vital Role of Primary Care in Tackling Liver Disease

A major new Lancet Gastroenterology & Hepatology Commission, published today, has shone a spotlight on the crucial role that primary care can play in preventing, detecting and managing liver disease. We were proud to contribute to ...
No results found.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.